Report Detail
Global Tissue Traceability Software Market 2026 by Company, Regions, Type and Application, Forecast to 2032
- RnM4731136 |
- 13 August, 2026 |
- Global |
- 131 Pages |
- GIR |
- Service & Software
According to our (Global Info Research) latest study, the global Tissue Traceability Software market size was valued at US$ 223 million in 2025 and is forecast to a readjusted size of US$ 357 million by 2032 with a CAGR of 6.7% during review period.
Tissue traceability software refers to a software system designed to manage the full lifecycle—including identity identification, status recording, movement tracking, compliance auditing, and recall management—of human tissues, cells, organs, grafts, pathological tissue samples, paraffin blocks, microscope slides, cell therapy products, and related biological samples. Its core objective is to ensure the existence of verifiable records for every step of the process, ranging from collection (from donors or patients), receipt, processing, testing, storage, transportation, and distribution to implantation or use, as well as return, decommissioning, and final disposal.
Driven by stricter clinical trial supervision, pathological diagnosis quality control and genetic resource administration rules, Tissue Traceability Software has evolved from simple barcode logging tools into full-lifecycle management platforms covering tissue collection, embedding, slicing, storage, transfer, testing and final disposal. The software is deeply integrated with LIS, HIS and digital pathology systems to break data silos and automatically record every custody change of specimens without manual entry. RFID positioning, mobile scanning and immutable blockchain audit trails become standard configurations to eliminate lost or mismatched tissue samples and meet global audit requirements such as FDA 21 CFR Part 11. Cloud SaaS and hybrid deployment models coexist: cloud subscription products serve mid-sized pathology labs and biorepositories, while on-premises customized versions remain mainstream for large hospitals and pharmaceutical R&D institutions. AI-powered intelligent alert functions automatically monitor sample expiration, abnormal temperature deviations and long-term stagnation of unprocessed specimens, shifting the system from passive record-keeping to proactive risk control. Demand expands beyond hospital pathology departments to CRO laboratories, biobanks and cell therapy research institutions. Vendors keep optimizing cross-lab collaborative tracing functions to support multi-center clinical research and inter-institutional specimen sharing, and compliance modules tailored for human genetic resource management turn into core differentiated competitiveness.
This report is a detailed and comprehensive analysis for global Tissue Traceability Software market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Tissue Traceability Software market size and forecasts, in consumption value ($ Million), 2021-2032
Global Tissue Traceability Software market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Tissue Traceability Software market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Tissue Traceability Software market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Tissue Traceability Software
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Tissue Traceability Software market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sapio Sciences, Soft Computer Consultants, LigoLab, Leica Biosystems, Sysmex, MAK-SYSTEM, Biolog-id, TrackCore, InVita Healthcare Technologies, Oracle Health, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Tissue Traceability Software market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Human Tissue Grafts
Cells & Cellular Therapy Products
Organs & Transplant Materials
Pathology Specimens
Others
Market segment by Scene
Tissue Bank Traceability Software
Implant Tracking Software
Pathology Specimen Traceability Software
Cell Therapy Traceability Software
Others
Market segment by Application
Hospitals & Surgical Centers
Tissue Banks & Eye Banks
Pathology Laboratories
Cell Therapy Manufacturers
Others
Market segment by players, this report covers
Sapio Sciences
Soft Computer Consultants
LigoLab
Leica Biosystems
Sysmex
MAK-SYSTEM
Biolog-id
TrackCore
InVita Healthcare Technologies
Oracle Health
Epic Systems
LabWare
LabVantage Solutions
Thermo Fisher Scientific
STARLIMS
Mindray
Dian Diagnostics
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Tissue Traceability Software product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Tissue Traceability Software, with revenue, gross margin, and global market share of Tissue Traceability Software from 2021 to 2026.
Chapter 3, the Tissue Traceability Software competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Tissue Traceability Software market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Tissue Traceability Software.
Chapter 13, to describe Tissue Traceability Software research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Classification of Tissue Traceability Software by Type
- 1.3.1 Overview: Global Tissue Traceability Software Market Size by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Global Tissue Traceability Software Consumption Value Market Share by Type in 2025
- 1.3.3 Human Tissue Grafts
- 1.3.4 Cells & Cellular Therapy Products
- 1.3.5 Organs & Transplant Materials
- 1.3.6 Pathology Specimens
- 1.3.7 Others
- 1.4 Classification of Tissue Traceability Software by Scene
- 1.4.1 Overview: Global Tissue Traceability Software Market Size by Scene: 2021 Versus 2025 Versus 2032
- 1.4.2 Global Tissue Traceability Software Consumption Value Market Share by Scene in 2025
- 1.4.3 Tissue Bank Traceability Software
- 1.4.4 Implant Tracking Software
- 1.4.5 Pathology Specimen Traceability Software
- 1.4.6 Cell Therapy Traceability Software
- 1.4.7 Others
- 1.5 Global Tissue Traceability Software Market by Application
- 1.5.1 Overview: Global Tissue Traceability Software Market Size by Application: 2021 Versus 2025 Versus 2032
- 1.5.2 Hospitals & Surgical Centers
- 1.5.3 Tissue Banks & Eye Banks
- 1.5.4 Pathology Laboratories
- 1.5.5 Cell Therapy Manufacturers
- 1.5.6 Others
- 1.6 Global Tissue Traceability Software Market Size & Forecast
- 1.7 Global Tissue Traceability Software Market Size and Forecast by Region
- 1.7.1 Global Tissue Traceability Software Market Size by Region: 2021 VS 2025 VS 2032
- 1.7.2 Global Tissue Traceability Software Market Size by Region, (2021-2032)
- 1.7.3 North America Tissue Traceability Software Market Size and Prospect (2021-2032)
- 1.7.4 Europe Tissue Traceability Software Market Size and Prospect (2021-2032)
- 1.7.5 Asia-Pacific Tissue Traceability Software Market Size and Prospect (2021-2032)
- 1.7.6 South America Tissue Traceability Software Market Size and Prospect (2021-2032)
- 1.7.7 Middle East & Africa Tissue Traceability Software Market Size and Prospect (2021-2032)
2 Company Profiles
- 2.1 Sapio Sciences
- 2.1.1 Sapio Sciences Details
- 2.1.2 Sapio Sciences Major Business
- 2.1.3 Sapio Sciences Tissue Traceability Software Product and Solutions
- 2.1.4 Sapio Sciences Tissue Traceability Software Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 Sapio Sciences Recent Developments and Future Plans
- 2.2 Soft Computer Consultants
- 2.2.1 Soft Computer Consultants Details
- 2.2.2 Soft Computer Consultants Major Business
- 2.2.3 Soft Computer Consultants Tissue Traceability Software Product and Solutions
- 2.2.4 Soft Computer Consultants Tissue Traceability Software Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Soft Computer Consultants Recent Developments and Future Plans
- 2.3 LigoLab
- 2.3.1 LigoLab Details
- 2.3.2 LigoLab Major Business
- 2.3.3 LigoLab Tissue Traceability Software Product and Solutions
- 2.3.4 LigoLab Tissue Traceability Software Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 LigoLab Recent Developments and Future Plans
- 2.4 Leica Biosystems
- 2.4.1 Leica Biosystems Details
- 2.4.2 Leica Biosystems Major Business
- 2.4.3 Leica Biosystems Tissue Traceability Software Product and Solutions
- 2.4.4 Leica Biosystems Tissue Traceability Software Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 Leica Biosystems Recent Developments and Future Plans
- 2.5 Sysmex
- 2.5.1 Sysmex Details
- 2.5.2 Sysmex Major Business
- 2.5.3 Sysmex Tissue Traceability Software Product and Solutions
- 2.5.4 Sysmex Tissue Traceability Software Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 Sysmex Recent Developments and Future Plans
- 2.6 MAK-SYSTEM
- 2.6.1 MAK-SYSTEM Details
- 2.6.2 MAK-SYSTEM Major Business
- 2.6.3 MAK-SYSTEM Tissue Traceability Software Product and Solutions
- 2.6.4 MAK-SYSTEM Tissue Traceability Software Revenue, Gross Margin and Market Share (2021-2026)
- 2.6.5 MAK-SYSTEM Recent Developments and Future Plans
- 2.7 Biolog-id
- 2.7.1 Biolog-id Details
- 2.7.2 Biolog-id Major Business
- 2.7.3 Biolog-id Tissue Traceability Software Product and Solutions
- 2.7.4 Biolog-id Tissue Traceability Software Revenue, Gross Margin and Market Share (2021-2026)
- 2.7.5 Biolog-id Recent Developments and Future Plans
- 2.8 TrackCore
- 2.8.1 TrackCore Details
- 2.8.2 TrackCore Major Business
- 2.8.3 TrackCore Tissue Traceability Software Product and Solutions
- 2.8.4 TrackCore Tissue Traceability Software Revenue, Gross Margin and Market Share (2021-2026)
- 2.8.5 TrackCore Recent Developments and Future Plans
- 2.9 InVita Healthcare Technologies
- 2.9.1 InVita Healthcare Technologies Details
- 2.9.2 InVita Healthcare Technologies Major Business
- 2.9.3 InVita Healthcare Technologies Tissue Traceability Software Product and Solutions
- 2.9.4 InVita Healthcare Technologies Tissue Traceability Software Revenue, Gross Margin and Market Share (2021-2026)
- 2.9.5 InVita Healthcare Technologies Recent Developments and Future Plans
- 2.10 Oracle Health
- 2.10.1 Oracle Health Details
- 2.10.2 Oracle Health Major Business
- 2.10.3 Oracle Health Tissue Traceability Software Product and Solutions
- 2.10.4 Oracle Health Tissue Traceability Software Revenue, Gross Margin and Market Share (2021-2026)
- 2.10.5 Oracle Health Recent Developments and Future Plans
- 2.11 Epic Systems
- 2.11.1 Epic Systems Details
- 2.11.2 Epic Systems Major Business
- 2.11.3 Epic Systems Tissue Traceability Software Product and Solutions
- 2.11.4 Epic Systems Tissue Traceability Software Revenue, Gross Margin and Market Share (2021-2026)
- 2.11.5 Epic Systems Recent Developments and Future Plans
- 2.12 LabWare
- 2.12.1 LabWare Details
- 2.12.2 LabWare Major Business
- 2.12.3 LabWare Tissue Traceability Software Product and Solutions
- 2.12.4 LabWare Tissue Traceability Software Revenue, Gross Margin and Market Share (2021-2026)
- 2.12.5 LabWare Recent Developments and Future Plans
- 2.13 LabVantage Solutions
- 2.13.1 LabVantage Solutions Details
- 2.13.2 LabVantage Solutions Major Business
- 2.13.3 LabVantage Solutions Tissue Traceability Software Product and Solutions
- 2.13.4 LabVantage Solutions Tissue Traceability Software Revenue, Gross Margin and Market Share (2021-2026)
- 2.13.5 LabVantage Solutions Recent Developments and Future Plans
- 2.14 Thermo Fisher Scientific
- 2.14.1 Thermo Fisher Scientific Details
- 2.14.2 Thermo Fisher Scientific Major Business
- 2.14.3 Thermo Fisher Scientific Tissue Traceability Software Product and Solutions
- 2.14.4 Thermo Fisher Scientific Tissue Traceability Software Revenue, Gross Margin and Market Share (2021-2026)
- 2.14.5 Thermo Fisher Scientific Recent Developments and Future Plans
- 2.15 STARLIMS
- 2.15.1 STARLIMS Details
- 2.15.2 STARLIMS Major Business
- 2.15.3 STARLIMS Tissue Traceability Software Product and Solutions
- 2.15.4 STARLIMS Tissue Traceability Software Revenue, Gross Margin and Market Share (2021-2026)
- 2.15.5 STARLIMS Recent Developments and Future Plans
- 2.16 Mindray
- 2.16.1 Mindray Details
- 2.16.2 Mindray Major Business
- 2.16.3 Mindray Tissue Traceability Software Product and Solutions
- 2.16.4 Mindray Tissue Traceability Software Revenue, Gross Margin and Market Share (2021-2026)
- 2.16.5 Mindray Recent Developments and Future Plans
- 2.17 Dian Diagnostics
- 2.17.1 Dian Diagnostics Details
- 2.17.2 Dian Diagnostics Major Business
- 2.17.3 Dian Diagnostics Tissue Traceability Software Product and Solutions
- 2.17.4 Dian Diagnostics Tissue Traceability Software Revenue, Gross Margin and Market Share (2021-2026)
- 2.17.5 Dian Diagnostics Recent Developments and Future Plans
3 Market Competition, by Players
- 3.1 Global Tissue Traceability Software Revenue and Share by Players (2021-2026)
- 3.2 Market Share Analysis (2025)
- 3.2.1 Market Share of Tissue Traceability Software by Company Revenue
- 3.2.2 Top 3 Tissue Traceability Software Players Market Share in 2025
- 3.2.3 Top 6 Tissue Traceability Software Players Market Share in 2025
- 3.3 Tissue Traceability Software Market: Overall Company Footprint Analysis
- 3.3.1 Tissue Traceability Software Market: Region Footprint
- 3.3.2 Tissue Traceability Software Market: Company Product Type Footprint
- 3.3.3 Tissue Traceability Software Market: Company Product Application Footprint
- 3.4 New Market Entrants and Barriers to Market Entry
- 3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
- 4.1 Global Tissue Traceability Software Consumption Value and Market Share by Type (2021-2026)
- 4.2 Global Tissue Traceability Software Market Forecast by Type (2027-2032)
5 Market Size Segment by Application
- 5.1 Global Tissue Traceability Software Consumption Value Market Share by Application (2021-2026)
- 5.2 Global Tissue Traceability Software Market Forecast by Application (2027-2032)
6 North America
- 6.1 North America Tissue Traceability Software Consumption Value by Type (2021-2032)
- 6.2 North America Tissue Traceability Software Market Size by Application (2021-2032)
- 6.3 North America Tissue Traceability Software Market Size by Country
- 6.3.1 North America Tissue Traceability Software Consumption Value by Country (2021-2032)
- 6.3.2 United States Tissue Traceability Software Market Size and Forecast (2021-2032)
- 6.3.3 Canada Tissue Traceability Software Market Size and Forecast (2021-2032)
- 6.3.4 Mexico Tissue Traceability Software Market Size and Forecast (2021-2032)
7 Europe
- 7.1 Europe Tissue Traceability Software Consumption Value by Type (2021-2032)
- 7.2 Europe Tissue Traceability Software Consumption Value by Application (2021-2032)
- 7.3 Europe Tissue Traceability Software Market Size by Country
- 7.3.1 Europe Tissue Traceability Software Consumption Value by Country (2021-2032)
- 7.3.2 Germany Tissue Traceability Software Market Size and Forecast (2021-2032)
- 7.3.3 France Tissue Traceability Software Market Size and Forecast (2021-2032)
- 7.3.4 United Kingdom Tissue Traceability Software Market Size and Forecast (2021-2032)
- 7.3.5 Russia Tissue Traceability Software Market Size and Forecast (2021-2032)
- 7.3.6 Italy Tissue Traceability Software Market Size and Forecast (2021-2032)
8 Asia-Pacific
- 8.1 Asia-Pacific Tissue Traceability Software Consumption Value by Type (2021-2032)
- 8.2 Asia-Pacific Tissue Traceability Software Consumption Value by Application (2021-2032)
- 8.3 Asia-Pacific Tissue Traceability Software Market Size by Region
- 8.3.1 Asia-Pacific Tissue Traceability Software Consumption Value by Region (2021-2032)
- 8.3.2 China Tissue Traceability Software Market Size and Forecast (2021-2032)
- 8.3.3 Japan Tissue Traceability Software Market Size and Forecast (2021-2032)
- 8.3.4 South Korea Tissue Traceability Software Market Size and Forecast (2021-2032)
- 8.3.5 India Tissue Traceability Software Market Size and Forecast (2021-2032)
- 8.3.6 Southeast Asia Tissue Traceability Software Market Size and Forecast (2021-2032)
- 8.3.7 Australia Tissue Traceability Software Market Size and Forecast (2021-2032)
9 South America
- 9.1 South America Tissue Traceability Software Consumption Value by Type (2021-2032)
- 9.2 South America Tissue Traceability Software Consumption Value by Application (2021-2032)
- 9.3 South America Tissue Traceability Software Market Size by Country
- 9.3.1 South America Tissue Traceability Software Consumption Value by Country (2021-2032)
- 9.3.2 Brazil Tissue Traceability Software Market Size and Forecast (2021-2032)
- 9.3.3 Argentina Tissue Traceability Software Market Size and Forecast (2021-2032)
10 Middle East & Africa
- 10.1 Middle East & Africa Tissue Traceability Software Consumption Value by Type (2021-2032)
- 10.2 Middle East & Africa Tissue Traceability Software Consumption Value by Application (2021-2032)
- 10.3 Middle East & Africa Tissue Traceability Software Market Size by Country
- 10.3.1 Middle East & Africa Tissue Traceability Software Consumption Value by Country (2021-2032)
- 10.3.2 Turkey Tissue Traceability Software Market Size and Forecast (2021-2032)
- 10.3.3 Saudi Arabia Tissue Traceability Software Market Size and Forecast (2021-2032)
- 10.3.4 UAE Tissue Traceability Software Market Size and Forecast (2021-2032)
11 Market Dynamics
- 11.1 Tissue Traceability Software Market Drivers
- 11.2 Tissue Traceability Software Market Restraints
- 11.3 Tissue Traceability Software Trends Analysis
- 11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry
12 Industry Chain Analysis
- 12.1 Tissue Traceability Software Industry Chain
- 12.2 Tissue Traceability Software Upstream Analysis
- 12.3 Tissue Traceability Software Midstream Analysis
- 12.4 Tissue Traceability Software Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
- 14.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Tissue Traceability Software. Industry analysis & Market Report on Tissue Traceability Software is a syndicated market report, published as Global Tissue Traceability Software Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Tissue Traceability Software market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
